OAKLAND, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced the Company will participate in the following upcoming investor conferences.
- The Jefferies Virtual Private MedTech Summit on December 6-7, 2023, with a fireside chat on December 6, 2023 at 12:30 PM ET;
- The Wells Fargo Virtual Private MedTech Symposium on December 6, 2023; and
- The Mizuho Medical Device and Healthcare Services Summit on December 6, 2023.
Promaxo is available to meet with investors at the conference; please request a meeting through the conference sites.
About Promaxo, Inc.
Promaxo was founded by a team of entrepreneurs and healthcare innovators to develop a minimally-invasive and patient-centric MRI and robotic platform. Based in Oakland, California, and backed by over 200 patents, the Company’s mission is to improve lives through state-of-the-art medical imaging, robotics and AI capabilities. With a compact and adaptable MRI, Promaxo is redefining the standard of care by improving the quality and speed of patient diagnosis and interventions. The Company has formed numerous long-term and strategic partnerships with investor groups and corporation as it drives commercialization of the Promaxo MRI system.
To learn more about the technology behind the MRI system and its scope, please visit: Promaxo.com.
LinkedIn: Promaxo
Twitter: @Promaxo
Facebook: Promaxo
Investors
Gilmartin Group
Vivian Cervantes
e: IR@promaxo.com
